PROF. MARTIN HAUER-JENSEN, M.D., PH.D.
Radiology at Markham St, Little Rock, AR
License number
Arkansas C-8156
Category
Radiology
Type
Surgery
Address
Address
4301 W Markham St, Little Rock, AR 72205
Phone
(501) 686-7912
(501) 224-7731
(501) 224-7731
Personal information
See more information about MARTIN HAUER-JENSEN at radaris.comName
Address
Phone
Little Rock, AR
Organization information
See more information about MARTIN HAUER-JENSEN at bizstanding.comMartin Hauer-Jensen MD,PHD
4301 W Markham St, Little Rock, AR 72205
Industry:
Surgeons
Phone:
(501) 686-7912 (Phone)
Martin Hauer-Jensen
Professional information
Director, Division Of Radiation Health
Position:
Director, Division of Radiation Health at UAMS, Associate Dean for Research, College of Pharmacy at UAMS, Professor of Pharmaceutical Sciences at UAMS, Professor of Surgery and Pathology at UAMS, Staff Surgeon at Central Arkansas Veterans Healthcare System
Location:
Little Rock, Arkansas Area
Industry:
Hospital & Health Care
Work:
UAMS
since Jul 2008
-
Director, Division of Radiation Health
UAMS
since Jul 2008
-
Associate Dean for Research, College of Pharmacy
UAMS
since Jul 2008
-
Professor of Pharmaceutical Sciences
UAMS
since Jul 1999
-
Professor of Surgery and Pathology
Central Arkansas Veterans Healthcare System
since Jul 1991
-
Staff Surgeon
Dr. Martin Hauer-Jensen, Little Rock AR - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
4301 W Markham St SUITE 406-2, Little Rock 72205
(501) 686-7912 (Phone), (501) 421-0022 (Fax)
UNIVERSITY HOSPITAL ARKANSAS
4301 W Markham St, Little Rock 72205
(501) 686-7000 (Phone), (501) 686-8139 (Fax)
(501) 686-7912 (Phone), (501) 421-0022 (Fax)
UNIVERSITY HOSPITAL ARKANSAS
4301 W Markham St, Little Rock 72205
(501) 686-7000 (Phone), (501) 686-8139 (Fax)
Languages:
English
Education:
Medical School
Universitetet I Oslo, Det Medisinske Fakultet
Graduated: 1977
Universitetet I Oslo, Det Medisinske Fakultet
Graduated: 1977
Method For Reducing Radiation Toxicity
US Patent:
6540976, Apr 1, 2003
Filed:
Sep 23, 1998
Appl. No.:
09/159334
Inventors:
Martin Hauer-Jensen - Little Rock AR
Paivi Aho - Helsinki, FI
Paivi Aho - Helsinki, FI
Assignee:
The Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
A61K 4900
US Classification:
424 91, 424 111, 424 165
Abstract:
Intestinal radiation injury (radiation enteropathy) is an important dose limiting factor during treatment of abdominal and pelvic tumors and a major determinant in the quality of life among cancer survivors. Inflammatory and fibrogenic mediators released by mucosal inflammatory cells are involved in the mechanisms of injury. Treatment with Orazipone decreases the toxicity following Gy radiation dose, as measured by histopathologic scoring, TGF-, IL-1, and ED- macrophage antigen immunoreactivity.
Martin Hauer-Jensen, Little Rock AR
Specialties:
Surgeon
Address:
4301 W Markham St, Little Rock, AR 72205
Use Of Statins In The Prevention And Treatment Of Radiation Injury And Other Disorders Associated With Reduced Endothelial Thrombomodulin
US Patent:
2010020, Aug 12, 2010
Filed:
Jan 29, 2010
Appl. No.:
12/657915
Inventors:
Martin K. Hauer-Jensen - Little Rock AR, US
Louis M. Fink - Little Rock AR, US
Jawahar Lal Mehta - Little Rock AR, US
Junru Wang - Little Rock AR, US
Jacob Joseph - Little Rock AR, US
Louis M. Fink - Little Rock AR, US
Jawahar Lal Mehta - Little Rock AR, US
Junru Wang - Little Rock AR, US
Jacob Joseph - Little Rock AR, US
Assignee:
The University of Arkansas for Medical Sciences - Little Rock AR
International Classification:
A61K 31/505, A61K 31/225, A61K 31/366, A61K 31/40, A61K 31/404
US Classification:
514275, 514548, 514460, 514423, 514419, 435375
Abstract:
The present invention discloses statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) consistently and significantly increased endothelial cell thrombomodulin protein and functional activity. Statins also abrogated the downregulation of thrombomodulin that occurs in response to radiation injury. These results indicate that preserving or restoring endothelial thrombomodulin expression and function by statins may be useful in a variety of disorders associated with widespread endothelial dysfunction such as sepsis, adult respiratory distress syndrome, and normal tissue radiation injury.
Tocopherol Derivatives And Methods Of Use
US Patent:
2013015, Jun 20, 2013
Filed:
Jun 2, 2011
Appl. No.:
13/701630
Inventors:
Philip J. Breen - Little Rock AR, US
K. Sree Kumar - Rockville MD, US
Cesar Compadre - Little Rock AR, US
Martin Hauer-Jensen - Little Rock AR, US
Kottayil Varughese - Little Rock AR, US
K. Sree Kumar - Rockville MD, US
Cesar Compadre - Little Rock AR, US
Martin Hauer-Jensen - Little Rock AR, US
Kottayil Varughese - Little Rock AR, US
Assignee:
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERAN AFFAIRS - Washington DC
THE BOARD OF TRUSTEES FOR THE UNIVERSITY OF ARKANSAS - Little Rock AR
THE BOARD OF TRUSTEES FOR THE UNIVERSITY OF ARKANSAS - Little Rock AR
International Classification:
C07D 311/72
US Classification:
514456, 549408
Abstract:
Tocol derivative compounds, compositions comprising these tocol derivatives and methods of using the tocol derivatives are provided herein. Specifically the tocol derivatives have a partially unsaturated hydrocarbon tail and are thus distinct from the tocopherols. The hydrocarbon tails do not have a trans carbon-carbon double bond in the second isoprene unit of the hydrocarbon tail and are distinct from the tocotrienols. The compounds are expected to allow improved interaction with the α-tocopherol transfer protein receptor than the tocotrienols and better bioactivity than the tocopherols.
Methods To Treat And/Or Prevent Radiation- And/Or Chemical-Induced Toxicity In Non-Malignant Tissue
US Patent:
2007023, Oct 11, 2007
Filed:
Dec 20, 2006
Appl. No.:
11/642505
Inventors:
Martin Hauer-Jensen - Little Rock AR, US
Chen Zong - Metuchen NJ, US
Chen Zong - Metuchen NJ, US
International Classification:
A61K 31/44, A61P 39/00
US Classification:
514337000
Abstract:
The present invention relates to methods useful for treating and/or preventing radiation- and/or chemical-induced toxicity in non-malignant tissue using a protease activated receptor-1 (PAR-1) inhibitor. In particular, use of a protease activated receptor-1 (PAR-1) inhibitor to treat and/or prevent acute and chronic adverse effects of radiation and/or chemical exposure (e.g., to one or more of the following: intestine, lung, oral mucosa, or other organs).
Prevention And Treatment Of Radiation Injury
US Patent:
2011014, Jun 16, 2011
Filed:
Sep 23, 2008
Appl. No.:
13/054756
Inventors:
Karl-Uwe Petersen - Aachen, DE
Martin Hauer-Jensen - Little Rock AR, US
Martin Hauer-Jensen - Little Rock AR, US
Assignee:
PAION Deutschland GmbH - Aachen
International Classification:
A61K 38/36, C07K 14/745, A61P 39/00
US Classification:
514 137, 530381
Abstract:
The invention relates to the field of radiation injury. More particularly, this invention relates to the protection against/prevention of and treatment of diseases caused by ionizing radiation by the use of thrombomodulin.